[Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program]. - Hellmis E; Schwentner C; Mandel P; Banek S; Gleißner J; Bögemann M (Aktuelle Urologie, 2023)